Cardiac Rhythm Management Devices – Market Insights – Europe

The European CRM device market will continue to grow modestly over the forecast period, driven primarily by rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and the increasing adoption of premium-priced devices such as CRT devices, single-chamber leadless pacemakers, and S-ICDs. However, revenue growth will be limited to some extent by ASP declines caused by increasing competition in the leadless pacemaker and S-ICD markets.

This Medtech 360 Report provides comprehensive data and analysis on the state of the European CRM device market from 2019 through 2033.

The highly saturated CRM device market will drive competitors to focus on innovation as a key strategy for growth.

Which segments are saturated, and which segments continue to see dynamic growth?

How do epidemiological trends and new technology influence growth in different pulse generator product segments?

How can individual competitors realize growth in this large but fairly mature market?

Adoption of novel devices will offset waning revenue for traditional devices in the European CRM market.

What is the predicted uptake of novel devices such as leadless pacemakers and S-ICDs? Will leadless pacemakers and S-ICDs become the standard of care?

To what extent will the uptake of leadless pacemakers and S-ICDs offset declining revenue in other markets?

How is the emergence of dual-chamber leadless pacemakers expected impact the traditional dual-chamber pacemaker market?

The generation of clinical data will be an important competitive factor for disruptive CRM devices.

Which key ongoing clinical trials are likely to influence the CRM device market?

How will the market share dynamics in different device segments be altered by ongoing clinical trials?

The competitive landscape in the European CRM device market is evolving.

Which competitors are positioned to gain market share with new devices, and how will they influence the market’s future landscape?

What is the predicted uptake of novel devices such as leadless pacemakers and S-ICDs?

How have innovations influenced CRM market share dynamics, and what strategies can competitors adopt to sustain or enhance their positions?